← Back to feedRead original →
VERIFIEDET Finance·neutral
Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard'
AI Summary
- ·Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license.
- ·The Bombay High Court criticized the regulator for acting in a high-handed and overboard manner.
- ·The FDA will issue a fresh show cause notice to Cipla Pharma following alleged irregularities.